Panacea Index Logo

Command Palette

Search for a command to run...

Fatty acid composition of cholesterol esters reflects dietary fat intake after dietary interventions in a multinational population.

Journal of clinical lipidology
May 5, 2023
Dominic Salamone et al. (10 authors)
Journal ArticleResearch Support, Non-U.S. Gov'tHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the relationship between changes in dietary fat intake (SFA vs. MUFA) and changes in fatty acid levels in serum cholesterol esters, as well as the impact of fish oil supplementation.

Results Summary

The study found that serum cholesterol ester fatty acid composition reflected dietary intake, with SFA intake linked to specific saturated fatty acids (C14:0, C15:0) and MUFA intake associated with oleic acid (C18:1 n-9). Fish oil supplementation significantly increased EPA (C20:5 n-3) and DHA (C22:6 n-3) levels, and Δ-9 desaturase activity was more reduced after the MUFA diet compared to the SFA diet.

Population

162 healthy individuals from a multinational population.

Effective Dosage

Not specified (diets contained a high proportion of SFA or MUFA; fish oil or placebo supplements were used).

Duration

3 months

Interactions

None mentioned

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
diet containing a high proportion of saturated fat (SFA)
increase
saturated fatty acids (especially myristic, C14:0, and pentadecanoic, C15:0) in serum lipid composition
162 healthy individuals
-
included
#1
diet containing a high proportion of monounsaturated fat (MUFA)
increase
monounsaturated fatty acids (oleic acid, C18:1 n-9) in serum lipid composition
162 healthy individuals
-
included
#2
SFA intake
increase
C14:0 and C15:0 levels
162 healthy individuals
-
related to
#3
MUFA intake
increase
C18:1 n-9 levels
162 healthy individuals
-
associated with
#4
fish oil supplementation
increase
eicosapentaenoic (C20:5 n-3) and docosahexaenoic (C22:6 n-3) acids
162 healthy individuals
-
induced a marked increase in
#5
MUFA diet
decrease
Δ-9 desaturase activity (palmitoleic acid/palmitic acid (C16:1/C16:0) ratio)
162 healthy individuals
0.31±0.10 vs 0.25±0.09, p<0.0001
more reduced
#6
SFA diet
decrease
Δ-9 desaturase activity (palmitoleic acid/palmitic acid (C16:1/C16:0) ratio)
162 healthy individuals
0.31±0.09 vs 0.29±0.08, p=0.006
reduced
#7
MUFA diet vs SFA diet
decrease
Δ-9 desaturase activity reduction
162 healthy individuals
p<0.0001
statistically significant difference between
#8
Abstract

BACKGROUND: The effects of different dietary fatty acids (FA) on cardiovascular risk still needs clarification. Plasma lipids composition may be a biomarker of FA dietary intake. PURPOSE: To evaluate in a composite population the relationships between changes in dietary fat intake and changes in FA levels in serum cholesterol esters. METHODS: In a multinational, parallel-design, dietary intervention (KANWU study), dietary intakes (3-day food record) and FA composition of serum cholesterol esters (gas-liquid chromatography) were evaluated at baseline and after 3 months in 162 healthy individuals, randomly assigned to a diet containing a high proportion of saturated (SFA) or monounsaturated (MUFA) fat, with a second random assignment to fish oil or placebo supplements. RESULTS: Main differences in serum lipid composition after the two diets included saturated (especially myristic, C14:0, and pentadecanoic, C15:0) and monounsaturated (oleic acid, C18:1 n-9) FA. C14:0 and C15:0 were related to SFA intake, while C18:1 n-9 was associated with MUFA intake. Fish oil supplementation induced a marked increase in eicosapentaenoic (C20:5 n-3) and docosahexaenoic (C22:6 n-3) acids. After the 3-month intervention, Δ-9 desaturase activity, calculated as palmitoleic acid/palmitic acid (C16:1/C16:0) ratio, was more reduced after the MUFA (0.31±0.10 vs 0.25±0.09, p<0.0001) than SFA diet (0.31±0.09 vs 0.29±0.08, p=0.006), with a statistically significant difference between the two groups (p<0.0001). CONCLUSIONS: This study shows that serum cholesterol ester FA composition can be used during randomized controlled trials as an objective indicator of adherence to experimental diets based on saturated and monounsaturated fat modifications, as well as fish oil supplementation.

Medical Subject Headings (MeSH)
HumansFatty AcidsCholesterol EstersDietary FatsFatty Acids, MonounsaturatedDietFish Oils
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality90/10
Citation Metrics
Total Citations1
Citations/Year0.5
Relative Citation Ratio0.41
NIH Percentile22.3%
Research Impact Scores
APT Score0.25
Weight Score2.62
Normalized Score0.72
Related Supplements